Yifan Zhang

Yifan Zhang

Auto-generated profile, based on publicly available information

Yifan Zhang

First Affiliated Hospital of Sun Yat-sen University 1 Guangzhou, Guangdong

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
XLXin Liu
Xin Liu
XWXin Wang
Xin Wang
QYQingxia Yang
Qingxia Yang
LLLi Luo
Li Luo
ZLZiqin Liu
Ziqin Liu
LXLixia Xu
Lixia Xu
Liver metastasis is the leading cause of mortality in patients with colorectal cancer. Given the significance of both epithelial–mesenchymal transition (EMT) of tumor cells and the immune microenvironment in colorectal cancer liver metastasis (CRLM), the interplay between them could hold the key for developing improved treatment options. We employed multiomics analysis of 130 samples from 18 patients with synchronous CRLM integrated with external datasets to comprehensively evaluate the interaction between immune cells and EMT of tumor cells in liver metastasis. Single-cell RNA sequencing analysis revealed distinct distributions of nonmalignant cells between primary tumors from patients with metastatic colorectal cancer (mCRC) and non-metastatic colorectal cancer, showing that Th17 cells were predominantly enriched in the primary lesion of mCRC. TWEAK, a cytokine secreted by Th17 cells, promoted EMT by binding to receptor Fn14 on tumor cells, and the TWEAK–Fn14 interaction enhanced tumor migration and invasion. In mouse models, targeting Fn14 using CRISPR-induced knockout or lipid nanoparticle–encapsulated siRNA alleviated metastasis and prolonged survival. Mice lacking Il17a or Tnfsf12 (encoding TWEAK) exhibited fewer metastases compared with wild-type mice, while cotransfer of Th17 with tumor cells promoted liver metastasis. Higher TWEAK expression was associated with a worse prognosis in patients with colorectal cancer. In addition, CD163L1+ macrophages interacted with Th17 cells, recruiting Th17 via the CCL4-CCR5 axis. Collectively, this study unveils the role of immune cells in the EMT process and identifies TWEAK secreted by Th17 as a driver of CRLM. Significance: TWEAK secreted by Th17 cells promotes EMT by binding to Fn14 on colorectal cancer cells, suggesting that blocking the TWEAK–Fn14 interaction may be a promising therapeutic approach to inhibit liver metastasis.

1 May 2025 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
KLKai Lei
Kai Lei
YLYichun Lei
Yichun Lei
ZWZeyao Wang
Zeyao Wang
ZYZhixin Ye
Zhixin Ye
JLJiawei Liu
Jiawei Liu
JTJiehui Tan
Jiehui Tan
Background: The SPP1+ tumor-associated macrophages (TAMs) have been implicated in tumor metastasis and immune evasion. However, the prognostic significance of SPP1+ TAMs in hepatocellular carcinoma (HCC) remains largely unexplored. This study aimed to identify SPP1+ TAMs-related genes and construct a model to predict overall survival (OS) in HCC patients.Methods: Single-cell RNA sequencing (scRNA-seq) datasets from HCC patients were analyzed to identify SPP1+ TAMs. SPP1+ TAMs-related risk score (STRS) was developed using Mendelian randomization (MR) analysis and Least Absolute Shrinkage and Selection Operator (LASSO) regression. HCC patients from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) cohorts were stratified into high- and low-STRS groups based on STRS. Kaplan-Meier survival analysis, receiver operating characteristic (ROC) curve analysis, and functional enrichment analysis were performed to assess the prognostic value of STRS.Results: SPP1+ TAMs exhibited strong associations with immunosuppressive functions. 16 SPP1+ TAMs-related genes were used to construct STRS. Patients in the high-STRS group had significantly worse OS than those in the low-STRS group (p < 0.001). ROC analysis demonstrated robust predictive power, with AUC values ranging from 0.685 to 0.748 for 1-year OS, 0.717 to 0.739 for 2-year OS, and 0.719 to 0.738 for 3-year OS. The STRS model also exhibited strong predictive capability for the distinction of drug resistance.Conclusion: This study identified SPP1+ TAMs-related genes as key prognostic indicators in HCC. The STRS model provides an effective tool for predicting patient survival and may facilitate personalized treatment strategies for HCC. These findings enhance the understanding of TAMs-driven immune modulation in HCC and highlight potential therapeutic targets for improving patient outcomes.

10 September 2025 in International Journal of Surgery
Verified
Journal Article
Open access
YHYutai Hao
Yutai Hao
CLChengcai Liang
Chengcai Liang
YZYifan Zhang
Yifan Zhang
XHXin Huang
Xin Huang
ZZZhoukai Zhao
Zhoukai Zhao
BZBaiwei Zhao
Baiwei Zhao
Introduction: Recent advancements in surgical techniques and perioperative care have improved cancer survival rates, yet post-operative comorbidity and mortality remain a critical concern. Despite progress in cancer control, systematic analyses of long-term mortality trends and competing risks in surgery-intervened cancer populations are lacking. This study aimed to quantify temporal patterns of post-operative mortality causes across 21 solid cancers and identify dominant non-cancer risk factors to inform survivorship care strategies. Methods: This retrospective, population-based cohort study analyzed data from 3 424 671 patients (including 2 371 058 surgical cases) diagnosed with 21 solid cancers between 1992 and 2021, sourced from the Surveillance, Epidemiology, and End Results database. Competing risk models were applied to assess cumulative mortality rates from index-cancer, non-index-cancer, and non-cancer causes, with stratification by cancer type. Surgical interventions were evaluated across short-term (30-day) and long-term follow-up periods, with primary outcomes focused on mortality attribution and secondary outcomes on temporal dominance shifts. Results: In this population-based retrospective cohort study of 3 424 671 patients with 21 solid cancers (1992–2021), non-cancer deaths surpassed index-cancer mortality in 14 malignancies (e.g., prostate, breast, colorectal), accounting for 48.7% of post-surgical deaths, with cardiovascular diseases and infections as primary contributors. By the 2020s, non-cancer causes emerged as the leading mortality driver in these cancers. However, index-cancer mortality remained predominant in pancreatic, ovarian, and brain tumors, highlighting the persistent therapeutic gaps. Surgical resection significantly altered mortality profiles for cancer population, with a 95.7% increase in non-cancer mortality for lung cancer and an 87.3% increase for pancreatic cancer ( P < 0.001), underscoring the critical need for enhanced post-operative comorbidity management. While 1-month post-surgical mortality improved over three decades for most solid cancers, disparities persisted in brain, biliary tract, and colorectal cancers. These findings advocate for multidisciplinary strategies prioritizing non-cancer comorbidities, particularly cardiovascular and infectious risks, to optimize long-term survival in cancer survivors. Conclusion: This study highlights a paradigm shift in post-operative mortality, with no-cancer cause of deaths now surpassing cancer-related deaths in most solid tumors. These findings underscore the urgency of integrating multidisciplinary care targeting cardiovascular health and infection prevention into survivorship programs.

19 May 2026 in Cancer Discovery
Verified
Journal Article
Open access
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Neutrophils are major players in innate immune immunity. However, their landscape and functions in colorectal cancer liver metastasis (CRLM) remain poorly understood. Here, using single-cell RNA sequencing and spatial-enhanced-resolution-omics-sequencing (Stereo-seq), we provide a comprehensive transcriptional landscape of tumor-associated neutrophils (TANs) in CRLM. Our analysis reveals that a terminally differentiated pro-tumor neutrophils subset (TAN1), characterized by a glycolysis signature and a senescent phenotype, is significantly enriched in liver metastasis and associated with poor prognosis. Mechanistically, TAN1 arises from other TAN subsets through the upregulation of BHLHE40, driven by glucose deprivation in the metastatic microenvironment. Functionally, TAN1 promotes angiogenesis via VEGFA and recruits immunosuppressive macrophages through potential CCL3L1-CCR1 signaling, thereby fostering an angiogenic immunosuppressive niche. As a result, neutrophil-specific knockout of Bhlhe40 in mice significantly promotes anti-tumor immunity and suppresses tumor growth. In sum, our data uncover the critical role of BHLHE40+ senescent-like neutrophils in shaping the immunosuppressive microenvironment of CRLM.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Table S3. Antibodies for IHC staining and flow cytometry.

1 October 2026
Verified
Other
Open access
PDF file
ZCZhihang Chen
Zhihang Chen
XRXiaoxue Ren
Xiaoxue Ren
YZYifan Zhang
Yifan Zhang
YKYoumei Kang
Youmei Kang
YYYe Yang
Ye Yang
MKMing Kuang
Ming Kuang
Figure S8. Role of neutrophil-specific Bhlhe40 knockout in the liver orthotopic implantation mouse model.